intellectual property


Notes on the Association Agreements with the European Union
The EU proposes that the parties be empowered to collaborate on the practical implementation of domestic rules regulating access to genetic resources and associated traditional knowledge, innovations, and practices on their territories, so as to guarantee compliance with those provisions. This is a case of interference with national sovereignty, unquestionably for the benefit of European pharmaceutical corporations.
Biodiversity in the FTAs with the USA and Europe: the crisis of the Andean integration process
While the Andean countries initially called for a balance to be struck between IPRs and the Andean countries’ interests – in particular education, culture, research, access to medicines, public health, food security, environmental protection, access to information, and technology transfer – Europe has insisted on measures to further entrench the intellectual property protection aspects of regional integration.
EU seeks to reestablish negotiations with Mercosur
The European Commission has proposed to reactivate its negotiations with the Mercosur bloc, stagnant since 2004, with the objective of reaching an association agreement.
Costa Rican legislators approve final piece of CAFTA
The last link in the free trade agreement with the United States passed through Costa Rica's Legislative Assembly
'Keep IPR away from free trade agreements'
Civil rights groups want the Government to keep Intellectual Property Rights outside the ambit of Free Trade Agreements being negotiated between India and several other regions including the European Union and Japan.
Pharma cos, public health groups want patent issue out of FTA talk with EU
Indian pharmaceutical firms and the network of public health groups have separately urged the government to keep patent-related issues out of the ongoing talks for the proposed India-EU free trade agreement.
Europe trade deal could hit Indian generic drugs
It took two years of secret suffering and gut-wrenching diarrhea to make Lumkile Sizila face the fact that he had HIV.
Pharma dept says no to IP clauses in FTAs
The Department of Pharmaceuticals (DoP) has firmly declined the commerce ministry proposal to incorporate intellectual property (IP) protection clauses, which go beyond the existing rules, as part of the free trade agreements (FTAs) being negotiated with the European Union (EU) and Japan.
Draft trade agreement worries technology companies
Technology companies and public interest groups are warning that an international trade agreement being drafted could expose Internet access providers, Web search engines and other online businesses to damaging legal risks.